{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:26:02Z","timestamp":1770963962578,"version":"3.50.1"},"reference-count":26,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2004,12,1]]},"DOI":"10.1080\/10428190400004521","type":"journal-article","created":{"date-parts":[[2004,12,14]],"date-time":"2004-12-14T14:45:11Z","timestamp":1103035511000},"page":"2445-2449","source":"Crossref","is-referenced-by-count":53,"title":["Bendamustine\/Mitoxantrone\/Rituximab (BMR): A Very Effective, Well Tolerated Outpatient Chemoimmunotherapy for Relapsed and Refractory CD20-positive Indolent Malignancies. Final Results of a Pilot Study"],"prefix":"10.1080","volume":"45","author":[{"given":"Rudolf","family":"Weide","sequence":"first","affiliation":[{"name":"Hematology\/Oncology Group Practice Neversstrasse 5 56068 Koblenz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Pandorf","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology Group Practice Neversstrasse 5 56068 Koblenz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Heymanns","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology Group Practice Neversstrasse 5 56068 Koblenz"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert","family":"K\u00f6ppler","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology Group Practice Neversstrasse 5 56068 Koblenz"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2009,7,1]]},"reference":[{"key":"CIT0001","first-page":"1414","volume":"75","author":"The French Cooperative Group on chronic lymphocytic leukemia","year":"1990","journal-title":"results of a randomized clinical trial on 612 Patients\", Blood"},{"issue":"5","key":"CIT0002","first-page":"631 \u2014 640","volume":"61","author":"Balfour J.A.","year":"2001","journal-title":"Drugs"},{"key":"CIT0003","first-page":"1013","volume":"110","author":"Ozegowski W.","year":"1971","journal-title":"Pharm"},{"key":"CIT0004","first-page":"22, 1079 \u2014 1084","author":"Anger G.","year":"1967","journal-title":"Deutsch. Gesundheitswes"},{"key":"CIT0005","first-page":"671 \u2014674","volume":"44","author":"Ruffert K.","year":"1989","journal-title":"Klin. Med"},{"key":"CIT0006","first-page":"1280","volume":"30","author":"Anger G.","year":"1975","journal-title":"Gesund-heitswes"},{"key":"CIT0007","first-page":"1\u2014 6","volume":"17","author":"Bremer K.","year":"1996","journal-title":"u. Ther"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.4.1262"},{"key":"CIT0009","unstructured":"McLaughlin, P., Cabanillas, F., Grillo-Lopez, A.J., et al. (1996) \"IDEC-C2B8 anti-CD20 antibody final report on a phase II pivotal trial in patients with relapsed low grade or follicular Lymphoma\", Blood, 88, 90a, Suppl 1."},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1080\/10428190290006107"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.4.1244"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830290307"},{"key":"CIT0013","author":"Jaffe ES.","year":"2001","journal-title":"Eds): WHO\u2014Classification of Tumours"},{"key":"CIT0014","doi-asserted-by":"crossref","first-page":"Pp 193","DOI":"10.1182\/asheducation-2002.1.193","author":"Kay N.E.","year":"2002","journal-title":"Hematology, Am. Soc. Hematol. Educ. Program"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.6.1840"},{"issue":"10","key":"CIT0016","first-page":"3554 \u2014 3561","volume":"99","author":"Keating, Mi., Flinn, I., Jain, V., et al.","year":"2002","journal-title":"Blood"},{"issue":"1","key":"CIT0017","first-page":"49","volume":"11","author":"Dreger P.","year":"2000","journal-title":"Oncol"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402530"},{"key":"CIT0019","first-page":"Pp 153","author":"Keating, Mi., Chiorazzi, N., Messmer, B., et al.","year":"2003","journal-title":"Hematology, Am. Soc. Hematol. Educ. Program"},{"key":"CIT0020","unstructured":"Leoni, L.M., Bailey, B., Reifert, J., et al. (2003) \"SDX-105 (Bendamustine), a clinically active antineoplastic agent possesses a unique mechanism of action\", Blood, 102, abstract 2363."},{"issue":"11","key":"CIT0021","first-page":"603 \u2014 609","volume":"128","author":"Bremer K","year":"2002","journal-title":"Clin. Oncol"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.1.268"},{"key":"CIT0023","unstructured":"Hiddemann, W., Dreyling, M.H., Forstpointer, R., et al. (2003) \"Combined Immuno-Chemotherapy (R-CHOP) significantly im-proves time to treatment failure in first line therapy of follicular lymphoma \u2014 Results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG)\", Blood, 102, abstract 352."},{"key":"CIT0024","unstructured":"Marcus, R., Imrie, K., Belch, A., et al. (2003) \"An International multi-centre, randomized, open-label phase III trial comparing rituximab added to CVP chemotherapy to CVP chemotherapy alone in untreated stage III\/IV follicular non-Hodgkin's lymphoma\", Blood, 102, abstract 87."},{"key":"CIT0025","unstructured":"Dreyling, M.H., Forstpointer, R., Repp, R., et al. (2003) \"Combined Immuno-Chemotherapy (R-FCM) results in superior remission and survival rates in recurrent follicular and mantle cell lymphoma \u2014 Final results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG)\", Blood, 102, abstract 351"},{"key":"CIT0026","unstructured":"Rummel, M., Kim, S.Z., Chow, KU., et al. (2003) \"Bendamustine and Rituximab act synergistically in vitro and are effective in the treatment of relapsed or refractory indolent and mantle-cell lymphomas\", Blood, 102, abstract 353."}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428190400004521","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T15:08:03Z","timestamp":1692112083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428190400004521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,1]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2004,12,1]]}},"alternative-id":["10.1080\/10428190400004521"],"URL":"https:\/\/doi.org\/10.1080\/10428190400004521","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,1]]}}}